Position in ATRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$862,468
+$549,599 QoQ
Shares Held
75,128
+13.6% QoQ
Ownership
0.748%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ATRA ranks #327 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ATRA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $862,468 | 75,128 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $312,869 | 66,146 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,128,471 | 62,381 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $867,336 | 60,526 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $464,248 | 60,136 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $348,552 | 58,679 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $728,642 | 54,744 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $379,833 | 46,720 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $362,754 | 42,677 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,498,062 | 2,158,591 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,103,026 | 2,150,150 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,073,331 | 2,076,575 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,270,800 | 2,031,553 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,552,276 | 1,914,578 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,047,067 | 1,843,618 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,695,604 | 1,771,324 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,332,195 | 1,711,450 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,617,474 | 1,681,106 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,538,528 | 1,620,465 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $26,363,513 | 1,472,822 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $23,547,738 | 1,514,324 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,383,100 | 1,419,436 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $23,645,139 | 1,204,541 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,782,117 | 1,063,435 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $12,889,700 | 884,674 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,043,982 | 827,730 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||